Relationship among age, race, medical funding, and cervical cancer survival

Journal of the National Medical Association

Volumn 102, Issue 3, 2010, Pages 199-205

  Federico, Christopher ^a   Alleyn, Jaime ^a   Dola, Chi ^a   Tafti, Sanaz ^a   Galandak, Jessica ^a   Jacob, Christian ^a   Bhuiyan, Azad ^b   Cheng, Joan ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b JACKSON STATE UNIVERSITY   (United States)

Author keywords

Age; Cervical cancer; Health insurance; Race ethnicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ETHNICITY; FEMALE; FUNDING; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; ONSET AGE; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER; WART VIRUS;

EID: 77950603817     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30526-5     Document Type: Article

References (28)

1. Parkin DM, Pisani P, Feriay J. Global cancer statistics. CA Cancer J Clin. 1999;49(1):33-64.
2. Fidler HK, Boyes DA, Worth AJ. Cervical cancer detection in British Columbia: A progress report. J Obsfet Gynecol Br Commonw. 1968:75(4):392-404.
3. MacGregor JE. Evaluation of mass screening programmes for cervical cancer in N.E. Scotland. Tumori. 1976:62(3):287-295.
4. Adami HO. Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. 1960-1984. Cancer. 1994;73(1):140-147.
5. American Cancer Society. Cancer facts and figures 2007. http://www.cancer.org.
6. Chen F, Trapido EJ, Davis K. Differences in stage at presentation of breast and gynecologic cancers among whites, blacks, and Hispanics. Cancer. 1994:73:2838-2842. (Pubitemid 24166274)
7. Leath CA III, Straughn JM Jr, Kirby TO, Huggins A, Partridge EE, Parham GP. Predictors of outcomes for women with Cervical Carcinoma. Gynecologic Oncology. 2005:99:432-436. (Pubitemid 41502857)
8. Howell EA, Chen YT, Concato J. Differences in cervical cancer mortality among black and white women. Obstet Gynecol. 1999:94(4):509-515. (Pubitemid 29460931)
9. Morgan MA, Behbakht K, Benjamin I, Berlin M, King SA, Rubin SC. Racial differences in survival from Gynecologic cancer. Obstet Gynecol. 1996;88(6):914-918. (Pubitemid 26391489)
10. Garner EIO. Cervical cancer: Disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev. 2003;12:242-247.
11. Ferrante JM, Gonzalea EC, Roetzheim RG, Pal N, Woodard L. Clinical and demographic predictors of late-stage cervical cancer. Arch fam Med. 2000:9:439-445.
12. Calle E, Flanders WD, Thun MJ, Martin LM. Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health. 1993:83:53-60. (Pubitemid 23019071)
13. The national Cancer Institute Screening Consortium for Underserved Women. Breast and cervical cancer screening among underserved women: Baseline survey results from six states. Arch Fam Med. 1995:4:617-624.
14. Anderson L, May D. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995:85:840-842.
15. Lee J, Parsons GF, Gentleman JF. Falling short of Pap test guidelines. Health Rep. 1998:10:9-19.
16. Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality rate between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993:329:103-109.
17. Krieger N, Quesenberry C Jr, Peng T, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-1992. Cancer Causes Control. 1999;10(6) :525-537
18. Sing GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in US incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004:101(5):1051-1057.
19. Bree N, Kessler L. Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview surveys. Am J Public Health. 1994;84:62-67.
20. Hiatt RA, Pasick RJ, Stewart S, et al. Community-based cancer screening for underserved women: Design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med. 2001;33:190-203.
21. Farley John, Risinger Jl, Rose GS, Maxwell GL Racial disparities in blacks with gynecologic cancers. Cancer 2007;110(2):234-243.
22. Licciardone JC, Wilkins JR III, Brownson RC, Chang JC. Cigarette smoking and alcohol consumption in the etiology of uterine cervical cancer. Int J Epidemiol. 1989;18:533-537.
23. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 1992;135:180-189.
24. Serraino D, Carrieri P, Pradier C, et al. Risk of invasive cervix cancer among women with, or at risk for, HIV infection. Int J Cancer. 1999:82:334-337.
25. Hawes S, Critchlow CW, Faye Niang MA, et al. Increased risk of high grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immuno-deficiency virus type 1 and 2 infections. J Infect Diseases. 2003;188:555-563.
26. Lorincz AT, Reid R. Association of human papillomavirus with gynecologic cancer. Curr Opin Oncol. 1989;1:123-132.
27. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992:79:328-337.
28. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr. 2003:31:3-13.1